Neoplasms Metastasis Withdrawn Phase 2 Trials for Ibandronate (DB00710)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00478270A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.Treatment